Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Underfunded, Overperforming: Endometrial cancer leads basic and translational science publications per NCI dollar.

Created on 15 Nov 2026

Authors

Michael T Richardson, Anne Gallivan, Lily Zello, Miles Morrow, Daniel S Kapp, John K Chan, Melissa Herbst-Kralovetz, Dana M Chase

Published in

Gynecologic oncology reports. Volume 68. Pages 102244. Epub Nov 03, 2026.

Abstract

To compare relative research funding and basic and translational science publications for gynecologic cancers vs. other common cancers, normalized to incidence and mortality rates.
SEER data were used to investigate incidence and deaths in the US from 2004 to 2024. Research funding was derived from National Cancer Institute (NCI) data. Google Scholar was utilized to identify oncology and medicine related journals with the highest H-indices. All abstracts on PubMed were reviewed and number of basic and translational science articles manually calculated.
In 2024, new diagnoses of breast, prostate, lung, and colorectal cancers totaled 313,510, 299,010, 234,580, and 152,810, respectively. Endometrial, ovarian, and cervical cancers accounted for 67,880, 19,680, and 13,820, respectively.NCI funding in 2023 was approximately $542.0 million for breast, $258.6 million for prostate, $435.0 million for lung, and $238.6 million for colorectal cancers, compared to $20.0 million, $132.0 million, and $20.7 million for endometrial, ovarian, and cervical cancers, respectively.Across the highest impact journals from 2004 to 2024, 24,169 basic/translational science publications were found: 8859 (breast), 4161 (prostate), 3537 (lung), 4321 (colorectal), 412 (endometrial), 2231 (ovarian), and 648 (cervical). When adjusted for incidence, ovarian cancer had the highest number of publications, at 220.9 publications per 100,000 cases. When adjusted for funding, endometrial cancer had the highest number of publications, at 23.1 publications per $1 million average annual NCI funding.
Funding relative to disease burden varies considerably among gynecologic cancers. Endometrial cancer receives the lowest NCI funding of any cancer studied when adjusted by incidence and mortality. Despite this, endometrial cancer produced the most basic and translational science publications per dollar.

PMID:
43034849
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement